221 related articles for article (PubMed ID: 7994251)
1. Bone marrow transplantation in Gaucher's disease: effect of mixed chimeric state.
Chan KW; Wong LT; Applegarth D; Davidson AG
Bone Marrow Transplant; 1994 Aug; 14(2):327-30. PubMed ID: 7994251
[TBL] [Abstract][Full Text] [Related]
2. [Gaucher's disease: pathogenesis, diagnosis and therapy].
Pregun I; Tulassay Z
Orv Hetil; 2004 Sep; 145(37):1883-90. PubMed ID: 15493618
[TBL] [Abstract][Full Text] [Related]
3. Gaucher's disease.
Patel AL; Shaikh WA; Khobragade AK; Soni HG; Joshi AS; Sahasrabudhe GS; Chole PV
J Assoc Physicians India; 2009 May; 57():410-1. PubMed ID: 19634291
[TBL] [Abstract][Full Text] [Related]
4. Bone-marrow transplantation in severe Gaucher's disease.
Rappeport JM; Ginns EI
N Engl J Med; 1984 Jul; 311(2):84-8. PubMed ID: 6377066
[TBL] [Abstract][Full Text] [Related]
5. Gaucher's disease. I. Modern enzymatic and anatomic methods of diagnosis.
Lee RE; Robinson DB; Glew RH
Arch Pathol Lab Med; 1981 Feb; 105(2):102-4. PubMed ID: 6779779
[TBL] [Abstract][Full Text] [Related]
6. Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher's disease using a plant cell system.
Shaaltiel Y; Bartfeld D; Hashmueli S; Baum G; Brill-Almon E; Galili G; Dym O; Boldin-Adamsky SA; Silman I; Sussman JL; Futerman AH; Aviezer D
Plant Biotechnol J; 2007 Sep; 5(5):579-90. PubMed ID: 17524049
[TBL] [Abstract][Full Text] [Related]
7. [Enzyme replacement therapy in type 1 Gaucher's disease].
Aggio MC; Fernández V; Marcilese M
Medicina (B Aires); 1994; 54(2):140-4. PubMed ID: 7997130
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of bone marrow failure in Gaucher's disease with low-dose modified glucocerebrosidase.
Mistry PK; Davies S; Corfield A; Dixon AK; Cox TM
Q J Med; 1992 Jul; 83(303):541-6. PubMed ID: 1484931
[TBL] [Abstract][Full Text] [Related]
9. [Gaucher's disease].
Hatano Y; Miura AB
Ryoikibetsu Shokogun Shirizu; 1998; (22 Pt 3):383-5. PubMed ID: 9851168
[No Abstract] [Full Text] [Related]
10. Allogeneic bone marrow transplantation for Gaucher disease--a case report.
Yen CC; Chiou TJ; Lin CY; Wang NH; Chen PM
Zhonghua Yi Xue Za Zhi (Taipei); 1997 Jun; 59(6):372-6. PubMed ID: 9294918
[TBL] [Abstract][Full Text] [Related]
11. [Gaucher's disease; current developments in the treatment of lysosomal metabolic disease].
Hollak CE; Aerts JM; Goudsmit R
Ned Tijdschr Geneeskd; 1991 Nov; 135(46):2162-4. PubMed ID: 1956441
[No Abstract] [Full Text] [Related]
12. [Gaucher's disease ].
Belmatoug N; Caubel I; Stirnemann J; Billette de Villemeur T
J Soc Biol; 2002; 196(2):141-9. PubMed ID: 12360743
[TBL] [Abstract][Full Text] [Related]
13. [Gaucher disease: diagnosis and treatment].
Fumić K; Stavljenić-Rukavina A; Mrsić M; Potocki K
Acta Med Croatica; 2004; 58(5):353-8. PubMed ID: 15756799
[TBL] [Abstract][Full Text] [Related]
14. Enzymic differentiation of neurologic and nonneurologic forms of Gaucher's disease.
Glew RH; Daniels LB; Clark LS; Hoyer SW
J Neuropathol Exp Neurol; 1982 Nov; 41(6):630-41. PubMed ID: 6813430
[TBL] [Abstract][Full Text] [Related]
15. Gene transfer and bone marrow transplantation with special reference to Gaucher's disease.
Karlsson S; Correll PH; Xu L
Bone Marrow Transplant; 1993; 11 Suppl 1():124-7. PubMed ID: 8448536
[TBL] [Abstract][Full Text] [Related]
16. The presence of an autologous marrow stromal cell layer increases glucocerebrosidase gene transduction of long-term culture initiating cells (LTCICs) from the bone marrow of a patient with Gaucher disease.
Wells S; Malik P; Pensiero M; Kohn DB; Nolta JA
Gene Ther; 1995 Oct; 2(8):512-20. PubMed ID: 8593601
[TBL] [Abstract][Full Text] [Related]
17. Gaucher's disease. Enzyme therapy is not enough.
Grabowski GA
Lancet; 2001 Dec; 358 Suppl():S29. PubMed ID: 11784578
[No Abstract] [Full Text] [Related]
18. Bone marrow transplantation from a cadaveric donor.
Kapelushnik J; Aker M; Pugatsch T; Samuel S; Slavin S
Bone Marrow Transplant; 1998 Apr; 21(8):857-8. PubMed ID: 9603417
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic delivery of proteins to macrophages: implications for treatment of Gaucher's disease.
Mistry PK; Wraight EP; Cox TM
Lancet; 1996 Dec; 348(9041):1555-9. PubMed ID: 8950883
[TBL] [Abstract][Full Text] [Related]
20. Marked clinical and histologic improvement in a patient with type-1 Gaucher's disease following long-term glucocerebroside substitution. A case report and review of current diagnosis and management.
Heukamp LC; Schröder DW; Plassmann D; Homann J; Büttner R
Pathol Res Pract; 2003; 199(3):159-63. PubMed ID: 12812317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
